Details of Host Protein-DME Interaction (HOSPPI)
General Information of Drug-Metabolizing Enzyme (DME ID: DME0525) | |||||
---|---|---|---|---|---|
DME Name | Inositol polyphosphate 4-phosphatase I (INPP4A), Homo sapiens | DME Info | |||
UniProt ID | |||||
EC Number | EC: 3.1.3.66 (Click to Show/Hide the Complete EC Tree) | ||||
Lineage | Species: Homo sapiens (Click to Show/Hide the Complete Species Lineage) | ||||
Interactome |
Disease Specific Interactions between Host Protein and DME (HOSPPI) | |||||
---|---|---|---|---|---|
ICD Disease Classification 02 Neoplasms | |||||
ICD-11: 2B30 Lymphoma | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Lymphoma | Significant hypomethylation | |||
Interaction Name | DNMT-INPP4A interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypomethylation p-value: 3.74E-10; delta-beta: -4.02E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the INPP4A gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Inositol polyphosphate 4-phosphatase I. As a result, the interaction between DNMT and INPP4A can significantly affect the drug-metabolizing process of Inositol polyphosphate 4-phosphatase I. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
ICD-11: 2C12 Liver cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
Non-coding RNA regulation | |||||
hsa-miR-3127-5p | Liver cancer | Suppression | |||
miRBase ID | |||||
Interaction Name | hsa-miR-3127-5p--INPP4A regulation | [1] | |||
Studied Cell Lines | Hepatocellular carcinoma cells | ||||
Description | hsa-miR-3127-5p is reported to suppress INPP4A mRNA translation by binding to the 3' untranslated region (3'UTR) of INPP4A mRNA, which leads to a decreased expression of the drug-metabolizing enzyme Inositol polyphosphate 4-phosphatase I. | ||||
References | |||||
---|---|---|---|---|---|
1 | MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulation. Oncotarget. 2015 Mar 20;6(8):6359-72. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.